论文部分内容阅读
目的:对小儿重症肺炎采用小剂量多巴胺联合多巴酚丁胺治疗的效果进行探讨。方法:选取我院2015年5月至2016年5月期间收治的108例重症肺炎患者,随机将患儿分为观察组与对照组,各54例。对照组采用常规药物治疗方法治疗,观察组给予小剂量多巴胺联合多巴酚丁胺方法治疗,对两组治疗的效果进行对比。结果:从治疗总有效率方面对比,观察组为96.30%,对照组为81.48%,观察组明显优于对照组,差异有统计学意义,P<0.05;从不良反应发生率方面对比,观察组为11.11%,对照组为9.26%,观察组与对照组差异不显著,无统计学意义,P>0.05。结论:对重症肺炎患者采用小剂量多巴胺联合多巴酚丁胺治疗,效果较好,不良反应发生率较低,在临床中有推广应用的价值。
Objective: To investigate the effect of low dose dopamine combined with dobutamine in children with severe pneumonia. Methods: A total of 108 patients with severe pneumonia admitted from May 2015 to May 2016 in our hospital were randomly divided into observation group and control group, with 54 cases in each group. The control group was treated by conventional drug therapy. The observation group was given low-dose dopamine combined with dobutamine for treatment, and the effects of the two groups were compared. Results: Compared with the control group, the observation group was significantly better than the control group, 96.30% in the observation group and 81.48% in the control group, P <0.05; compared with the incidence of adverse reactions, the observation group Which was 11.11% in the control group and 9.26% in the control group. There was no significant difference between the observation group and the control group (P> 0.05). Conclusion: The treatment of severe pneumonia with low-dose dopamine combined with dobutamine is better and the incidence of adverse reactions is lower. It has the value of popularization and application in clinical practice.